Search the Newsreel

Legacy Housing (NASDAQ:LEGH) Stock Rating Upgraded by Wall Street Zen

Collegium Pharmaceutical (NASDAQ:COLL) Cut to "Hold" at Wall Street Zen

Wall Street Zen has downgraded Collegium Pharmaceutical (NASDAQ:COLL) from "Buy" to "Hold," leading to mixed analyst views but a consensus "Moderate Buy" rating with an average price target of $52.60. Despite exceeding Q2 earnings expectations with strong ADHD portfolio growth, the company lowered its …

Collegium Pharmaceutical (NASDAQ:COLL) Releases Earnings Results, Beats Estimates By $0.20 EPS

Collegium Pharmaceutical (NASDAQ:COLL) announced quarterly earnings that surpassed analyst estimates, reporting $1.92 EPS against a consensus of $1.72, and revenue of $199.88 million. The company experienced strong growth in its ADHD portfolio, particularly with JORNAY PM and the recent AZSTARYS acquisition, but faced declines …

Allegiant Travel Company 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:ALGT) 2026-08-07

Leggett & Platt (LEG) Stock Flatlines As 6x P E Doubts Deepen

Leggett & Platt (LEG) stock remained flat after its Q2 2026 earnings report, despite a 13% drop in the preceding month, leaving investors to ponder if its 6x P/E ratio represents a bargain or a value trap. The company's Q2 revenue declined 5.5% year-over-year, …

Allegro Microsystems (ALGM) awards stock to non-employee director Puma

Allegro Microsystems (ALGM) has granted 4,251 shares of common stock to non-employee director Mary G. Puma as part of her annual equity compensation. This award, fully vested and unrestricted, increases her direct holdings to 21,734 shares. The transaction, reported on August 5, 2026, was …

Allegro Microsystems (ALGM) awards director 4,251 fully vested shares

Allegro Microsystems (ALGM) director Joseph R. Martin was

Form 8K Allegro Microsystems Inc For: 7 August By Investing.com

This article reports on Allegro Microsystems Inc.'s Form 8K filing for August 7th. The brief notice highlights the company and its stock performance, noting a 3.11% increase. The content is primarily a placeholder for financial news, surrounded by various market data.

Allegiant Travel Is Maintained at Neutral by Susquehanna

Susquehanna has maintained its "Neutral" rating on Allegiant Travel. The article indicates no change in the firm's outlook for the company.

(ATI) Movement Within Algorithmic Entry Frameworks

The article provides an algorithmic analysis of Ati Inc. (NYSE: ATI), identifying strong sentiment across all horizons and no resistance levels above the current price, suggesting upside potential. It outlines specific institutional trading strategies including position trading, momentum breakout, and risk hedging, along with …

Legend Biotech Details Compensation Package for Interim CEO Alan Bash

Legence Corp. (NASDAQ: LGN) Schedule 13G/A shows Blackstone-linked holders at 46.9%

Legence Corp.'s major stockholder group, including Legence Parent entities and Blackstone-affiliated funds, has reported a significant ownership stake in the company's Class A common stock through a Schedule 13G/A filing. As of June 30, 2026, these Blackstone-related reporting persons beneficially own 50,647,086 Class A …

First Trust Advisors LP Cuts Stock Holdings in LegalZoom.com, Inc. $LZ

First Trust Advisors LP reduced its stake in LegalZoom.com (NASDAQ:LZ) by 28.5% in the first quarter, selling over 211,000 shares but still retaining over 530,000 shares valued at approximately $3 million. Despite this, other institutional investors like Arrowstreet Capital, Goldman Sachs, and Boston Partners …

Legacy Housing Corporation $LEGH Shares Purchased by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP increased its stake in Legacy Housing Corporation (LEGH) by 7.0% in the first quarter, purchasing over 62,000 additional shares to own 4.01% of the company. Other institutional investors also adjusted their positions. Legacy Housing recently reported strong quarterly earnings of …

Piper Sandler Reiterates Neutral Rating for Collegium Pharmaceutical (NASDAQ:COLL)

Allegion plc Stock 12‑Month Price Target Raised to $175.1, Implies 4% Upside

Allegion plc's average stock price target has been raised to $175.1 from $173.3 by 10 analysts, with forecasts ranging from $160 to $200 per share. This updated target suggests a potential 4% upside based on the recent closing price. The consensus rating for Allegion …

Allegro MicroSystems shareholders elect directors and approve proposals at annual meeting

Allegro MicroSystems (NASDAQ: ALGM) shareholders elected three Class III Directors, ratified the appointment of PricewaterhouseCoopers LLP as their independent accounting firm for fiscal year 2027, and approved the company's executive compensation on an advisory basis. These decisions were made during the company's Annual Meeting …

Insider Selling: Allegion (NYSE:ALLE) SVP Sells $168,250.00 in Stock

Allegion SVP Vincent Wenos sold 1,000 shares of the company's stock for $168,250, reducing his direct ownership by 7.64%. Despite this insider selling, Allegion's stock rose 0.5% and the company exceeded Q2 analyst expectations with EPS of $2.40 and revenue of $1.15 billion. The …

LegalZoom: Cracks Are Beginning To Show (Rating Downgrade) (NASDAQ:LZ)

Collegium Pharmaceutical, Inc. Stock 12‑Month Price Target Cut to $51.2, Implies 43% Upside

Collegium Pharmaceutical, Inc. (COLL) has seen its average 12-month price target reduced from $53.6 to $51.2 by 5 analysts, with individual forecasts ranging from $43 to $60. Despite this cut, the updated target still implies a significant 43% potential upside from its August 5 …

Collegium Pharmaceutical (COLL) Stock May Trade At A Discount Even After A 60% Return

Collegium Pharmaceutical (COLL) stock has seen a nearly 60% return over the past five years but may still be trading at a discount. Despite recent weakness, the company screens as undervalued in most measures, with its current P/E ratio of 12.6x being below the …

Is Leggett & Platt (LEG) a Great Value Stock Right Now?

The article analyzes Leggett & Platt (LEG) as a potential value stock, highlighting its Zacks Rank #2 (Buy) and an "A" grade for Value. It points to favorable valuation metrics such as its P/E, P/S, and P/CF ratios compared to industry averages. The analysis …

State Street Corporation (ALLE) discloses 4.35M-share, 5.1% Allegion plc holding

State Street Corporation has disclosed a passive investment of 4,348,530 shares, representing a 5.1% stake, in Allegion plc common stock as of June 30, 2026. The holding is managed through various State Street Global Advisors entities and related investment advisers, with shared voting power …

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Consensus Recommendation of "Moderate Buy" by Analysts

Legend Biotech Corporation (NASDAQ:LEGN) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $55.29. While the company reported a 56.5% year-over-year revenue increase to $305.1 million, it missed EPS estimates with an adjusted loss of $0.03 per …

Legacy Housing Corp Q2 revenue USD 66.3 million (Aug. 5)

Legacy Housing Corporation reported second-quarter revenue of $66.3 million. The article, published on MarketScreener, notes the company's financial results for the quarter ended June 30, 2026. Legacy Housing specializes in building, selling, and financing manufactured homes and tiny houses, primarily in the southern United …

Collegium Pharmaceutical, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:COLL) 2026-08-07

Collegium Pharmaceutical, Inc. (COLL) released its Q2 2026 earnings call presentation. The company reported an EPS of $1.92, beating estimates by $0.16, and revenue of $199.88M, which missed estimates by $1.07M but represented a 6.32% year-over-year increase. This presentation provides details on their financial …

The Legal & General share price is suddenly giving Rolls-Royce a run for its money!

Collegium Pharmaceutical Inc (COLL) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Collegium Pharmaceutical Inc (COLL), detailing its current price momentum score, support and resistance levels, and indicator readings. It also covers moving average data and offers a technical summary, suggesting the stock is currently suitable for range-bound swing …

Pacer Advisors Inc. Sells 39,468 Shares of ATI Inc. $ATI

Pacer Advisors Inc. significantly reduced its stake in ATI Inc. by selling 39,468 shares in the first quarter, retaining a holding worth approximately $3.15 million. This move contrasts with other major institutional investors like State Street, Capital Research, and Invesco, which increased their positions …

Sei Investments Co. Has $3.87 Million Stock Holdings in Leggett & Platt, Incorporated $LEG

Sei Investments Co. significantly increased its stake in Leggett & Platt, Incorporated by 79.4% in the first quarter, now holding 391,653 shares valued at approximately $3.87 million. Despite institutional ownership accounting for 64.23% of the stock, analysts maintain a "Hold" rating with a consensus …

Legacy Housing (LEGH) Stock Draws Attention After Record Profit Run

LegalZoom.com, Inc. Stock 12‑Month Price Target Cut to $7.9, Implies 2% Downside

LegalZoom.com, Inc.'s average 12-month stock price target has been lowered from $8.3 to $7.9 by analysts, implying a 2% potential downside from its Aug. 5 closing price. Despite this reduction, the consensus rating from 8 analysts remains "Buy," with a breakdown of 3 Buys …

Somnigroup and Leggett & Platt both see Q2 sales decline

Somnigroup International reported a 3% decline in Q2 2026 sales to $1,823.5 million, though net income increased by 12.0%. The company is proceeding with its $2.5 billion acquisition of Leggett & Platt, expected to close by Q3 2026. Separately, Leggett & Platt also announced …

How Investors Are Reacting To Leggett & Platt (LEG) Weaker Q2 Results And Lower Dividend

Leggett & Platt (LEG) reported weaker Q2 2026 results with lower sales and net income year-over-year, alongside a reduced dividend, indicating ongoing profitability pressures. The company's investment narrative is challenged by weak demand, margin pressure, and competitive discounting, despite potential benefits from tariffs and …

ATI (NYSE:ATI) Announces Earnings Results, Beats Estimates By $0.20 EPS

Collegium Pharmaceutical Releases Q2 2026 Financial Results

Collegium Pharmaceutical Inc. reported mixed Q2 2026 financial results, with adjusted earnings of $1.92 per share exceeding expectations, but revenue of $199.9M slightly missing estimates. The company's product, JORNAY PM, showed significant revenue growth of 41.0%, contributing to the positive outlook. Management issued full-year …